Hsbc Holdings PLC Atai Life Sciences N.V. Transaction History

Hsbc Holdings PLC

  • $160 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.17 - $2.7 $3,992 - $9,212
-3,412 Reduced 23.67%
11,003 $19,000
Q4 2022

Feb 14, 2023
SELL
$2.38 - $3.55 $6,133 - $9,148
-2,577 Reduced 15.17%
14,415 $38,000
Q3 2022

Nov 14, 2022
BUY
$3.14 - $4.87 $53,354 - $82,751
16,992 New
16,992 $57,000

Others Institutions Holding ATAI

# of Institutions
97
Shares Held
12.8M
Call Options Held
9.2K
Put Options Held
118K
View Full List

About ATAI Life Sciences N.V.

ATAI Quotes by TradingView
  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $189M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email